JP2014527040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527040A5 JP2014527040A5 JP2014521801A JP2014521801A JP2014527040A5 JP 2014527040 A5 JP2014527040 A5 JP 2014527040A5 JP 2014521801 A JP2014521801 A JP 2014521801A JP 2014521801 A JP2014521801 A JP 2014521801A JP 2014527040 A5 JP2014527040 A5 JP 2014527040A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- pharmaceutical composition
- seq
- composition according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509340P | 2011-07-19 | 2011-07-19 | |
| US61/509,340 | 2011-07-19 | ||
| US201261662337P | 2012-06-20 | 2012-06-20 | |
| US61/662,337 | 2012-06-20 | ||
| PCT/US2012/047468 WO2013013085A2 (en) | 2011-07-19 | 2012-07-19 | Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014527040A JP2014527040A (ja) | 2014-10-09 |
| JP2014527040A5 true JP2014527040A5 (enExample) | 2015-08-20 |
Family
ID=47558730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521801A Pending JP2014527040A (ja) | 2011-07-19 | 2012-07-19 | 抗−線維化ペプチド並びに線維化を特徴とする疾患及び障害を治療するための方法における該抗−線維化ペプチドの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140057831A1 (enExample) |
| EP (1) | EP2734220A4 (enExample) |
| JP (1) | JP2014527040A (enExample) |
| CN (2) | CN103890003B (enExample) |
| AU (1) | AU2012283924A1 (enExample) |
| BR (1) | BR112014001268A2 (enExample) |
| CA (1) | CA2842330A1 (enExample) |
| HK (1) | HK1198333A1 (enExample) |
| IL (1) | IL230510A0 (enExample) |
| RU (1) | RU2014105513A (enExample) |
| WO (1) | WO2013013085A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170232276A1 (en) * | 2014-09-30 | 2017-08-17 | Primegen Biotech, Llc | Treatment of fibrosis using deep tissue heating and stem cell therapy |
| US20160137714A1 (en) * | 2014-11-12 | 2016-05-19 | Thrasos Innovation, Inc. | Peptides with enhanced stability and their use in methods for treating diseases |
| EP3289073A4 (en) | 2015-05-01 | 2019-07-17 | University of Miami | METHOD AND COMPOSITIONS FOR THE CONVERSION OF NON-ENDOCRINE PANCREATIC TISSUE IN INSULIN-PRODUCING CELLS |
| CN114181281A (zh) * | 2015-05-12 | 2022-03-15 | 加利福尼亚大学董事会 | 用于炎症和纤维化的肽治疗 |
| BR112017026209A2 (pt) * | 2015-06-05 | 2018-11-27 | Ibio, Inc. | fragmentos e variantes de endostatinas para uso no tratamento de fibrose |
| WO2019133950A1 (en) * | 2017-12-30 | 2019-07-04 | The Regents Of The University Of Colorado, A Body Corporate | Smad7 for treatment and prevention of posterior capsule opacification |
| JP6933394B2 (ja) * | 2018-09-06 | 2021-09-08 | マリン エッセンス バイオサイエンシズ コーポレーション オブ ユーエスエーＭａｒｉｎｅ Ｅｓｓｅｎｃｅ Ｂｉｏｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ ｏｆ ＵＳＡ | 組織再生誘導のためのバイオマテリアルデバイスおよび局所用組成物 |
| CA3117323A1 (en) * | 2018-10-22 | 2020-04-30 | William D. Carlson | Therapeutic combinations of tdfrps and additional agents and methods of use |
| US20210008173A1 (en) * | 2019-07-10 | 2021-01-14 | Musc Foundation For Research Development | Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury |
| CN111704653B (zh) * | 2020-06-08 | 2023-10-03 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
| WO2022197855A1 (en) * | 2021-03-16 | 2022-09-22 | Therapeutics By Design, LLC | Therapeutic combinations of tdfrps and additional agents and methods of use for the reversal of fibrosis |
| CN113069531B (zh) * | 2021-04-09 | 2023-02-28 | 南开大学 | 一种防疤痕皮肤创伤修复用水凝胶及其制备方法 |
| CN116768974A (zh) * | 2022-03-11 | 2023-09-19 | 中山大学 | 用于预防和/或治疗肾纤维化的多肽化合物 |
| EP4601667A1 (en) | 2022-10-10 | 2025-08-20 | Therapeutics by Design, LLC | Tissue differentiation factor related polypeptides (tdfrps) for the treatment of myocardial injury |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4847634B2 (ja) * | 1996-03-22 | 2011-12-28 | ストライカー・コーポレーション | 中枢神経系の虚血または外傷の機能的回復を増大させる方法 |
| EP2392659B1 (en) * | 2002-06-17 | 2015-01-14 | Thrasos Innovation, Inc. | Single domain TDF-related compounds and analogs thereof |
| CA2571218C (en) * | 2004-06-17 | 2015-11-03 | William D. Carlson | Tdf-related compounds and analogs thereof |
| EP2497780B1 (en) * | 2005-09-20 | 2015-04-15 | Thrasos Innovation, Inc. | TDF-related compounds and analogs thereof |
| US20110275574A1 (en) * | 2009-01-16 | 2011-11-10 | Agency For Science, Technology And Research | Method of inhibiting proliferation of hepatic stellate cells |
| EP2401614A1 (en) * | 2009-02-27 | 2012-01-04 | OSI Pharmaceuticals, LLC | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| EP2427494B1 (en) * | 2009-05-08 | 2017-10-18 | Novartis AG | Methods of modulating fibrosis using bone morphogenetic protein-9 (bmp-9) modulators |
-
2012
- 2012-07-19 US US13/553,685 patent/US20140057831A1/en not_active Abandoned
- 2012-07-19 CN CN201280045650.7A patent/CN103890003B/zh not_active Expired - Fee Related
- 2012-07-19 HK HK14111848.5A patent/HK1198333A1/zh unknown
- 2012-07-19 WO PCT/US2012/047468 patent/WO2013013085A2/en not_active Ceased
- 2012-07-19 RU RU2014105513/04A patent/RU2014105513A/ru not_active Application Discontinuation
- 2012-07-19 CA CA2842330A patent/CA2842330A1/en not_active Abandoned
- 2012-07-19 AU AU2012283924A patent/AU2012283924A1/en not_active Abandoned
- 2012-07-19 CN CN201610543024.0A patent/CN106478776A/zh active Pending
- 2012-07-19 BR BR112014001268A patent/BR112014001268A2/pt not_active IP Right Cessation
- 2012-07-19 EP EP12814119.9A patent/EP2734220A4/en not_active Withdrawn
- 2012-07-19 JP JP2014521801A patent/JP2014527040A/ja active Pending
-
2014
- 2014-01-16 IL IL230510A patent/IL230510A0/en unknown
-
2015
- 2015-08-05 US US14/818,652 patent/US20160058829A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527040A5 (enExample) | ||
| RU2014105513A (ru) | Противофиброзные пептиды и их применение в способах лечения заболеваний и расстройств, характеризующихся фиброзом | |
| JP2015517488A5 (enExample) | ||
| HRP20200889T1 (hr) | Upotreba dugodjelujućih peptida glp-1 | |
| JP2015517489A5 (enExample) | ||
| JP2015057436A5 (enExample) | ||
| JP2011528332A5 (enExample) | ||
| HRP20180425T1 (hr) | Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline | |
| MX2018015315A (es) | Agentes antivirales contra la hepatitis b. | |
| JP2013542247A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| NZ708501A (en) | Treatment of pulmonary disease | |
| JP2013509429A5 (enExample) | ||
| JP2015513318A5 (enExample) | ||
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| JP2016534153A5 (enExample) | ||
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| BR112014015142A2 (pt) | di-hidropirimidinoisoquinolinonas e composições farmacêuticas das mesmas para o tratamento de distúrbios inflamatórios | |
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| JP2015533791A5 (enExample) | ||
| JP2015526391A5 (enExample) | ||
| JP2012529293A5 (enExample) | ||
| MX2014013851A (es) | Composiciones farmaceuticas topicas que comprenden terbinafina y urea. | |
| JP2011528334A5 (enExample) | ||
| EA033437B9 (ru) | Fc-гамма-рецептор iib и его применение для лечения или предупреждения воспалительных и/или аутоиммунных заболеваний |